PCR detection of chromosomal translocations and small insertion/deletion mutations is challenging when potential amplicon size varies greatly. Molecular diagnostic laboratories face such difficulties with the BCL2-IGHtranslocation in follicular lymphoma and with internal tandem duplication mutation of the FLT3 gene in leukemia, where breakpoints are widely distributed, mutations may be multiple, signal strength is low, and background noise is elevated. We developed a strategy, called ⌬-PCR, that ensures PCR specificity and identifies individual breakpoints. ⌬-PCR uses two forward primers (external and internal) and a reverse primer simultaneously. The internal primer functions as a probe with a defined distance ⌬ from the external primer. For follicular lymphoma, we prepared upstream, BCL2-specific primers for potential breakpoints to pair with a common, downstream VLJH primer. Multiplexed PCR amplicons are sized by capillary electrophoresis. Each of the upstream pairs has a defined interval separating them that uniquely identifies the breakpoint. The presence of two amplicons with a defined size difference confirms validity of the rearrangement and identity of the specific breakpoint, even if signal strength is low. By testing 40 follicular lymphoma and 12 control specimens from formalin-fixed, paraffinembedded (FFPE) blocks, we showed that multiplex ⌬-PCR is a simple, sensitive strategy to identify translocations with multiple breakpoints or partners. The strategy was also applied to detect minor leukemic clones with internal tandem duplication mutations and could have broader applications for other insertion/deletion and duplication mutations. Chromosomal translocations and small insertion/deletions occur in specific hematological malignancies and solid tumors, and are often definitional genetic events.
1,2Translocations involve breakage and fusion of two or more chromosomes, and insertion/deletions (as considered in the present study) involve breakage within one chromosome. The detection of these chromosomal abnormalities by conventional cytogenetics study, standard Southern blot analysis, fluorescence in situ hybridization (FISH), PCR, and reverse-transcription PCR (RT-PCR) has been used to diagnose specific malignancies and also to monitor minimal residual cancer cells.
3Depending on the specific breakpoint and fusion, chromosomal translocations are classified into two categories.1 Breakage within genes leads to a fusion transcript producing an oncogenic chimeric protein, as in chronic myelogenous leukemia (BCR-ABL1) and synovial sarcoma (SYT-SSX1 or SYT-SSX2). 4 -6 In these cases, diagnostic PCR using genomic DNA is difficult because the potential breakpoint regions in the introns span large distances; however, the fusion transcript can be detected with high sensitivity and specificity by RT-PCR across the involved exon junction at the RNA level. 7,8 The second mechanism of translocation-induced oncogenesis, particularly common in lymphoid malignancies, involves the approximation of an oncogene and an ac...